MyFinsight
Home
Blog
About
Contact
Download
Download image
Net increase
(decrease) in cash and cash...
-$3,834,664
Net proceeds from
sale of equity
$3,019,528
Proceeds from employee
stock purchases and...
$131,410
Share-based compensation
$630,386
Accrued liabilities and
other current...
$206,262
Other operating
assets and liabilities
-$157,561
Depreciation
$36,066
Prepaid expenses
-$11,910
Net cash provided by
(used in) financing...
-$2,100,830
Net cash used in
operating activities
-$1,732,597
Effect of exchange rate
changes on cash
-$1,237
Canceled cashflow
$3,150,938
Canceled cashflow
$1,042,185
Repayment of related party
note
$5,000,000
Net loss
-$2,742,368
Payment for shares to
satisfy tax...
$251,768
Accounts payable
-$32,414
Back
Back
Cash Flow
source: myfinsight.com
MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. (INKT)